![Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study - The Lancet Regional Health – Europe Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/c4395348-b5f4-4b26-bb1e-45ecc1edcf10/gr2_lrg.jpg)
Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study - The Lancet Regional Health – Europe
![Frontiers | The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study Frontiers | The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/799675/799675_Thumb_400.jpg)
Frontiers | The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
![Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study | The BMJ Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study | The BMJ](https://www.bmj.com/sites/default/files/sites/defautl/files/attachments/bmj-article/2016/01/contraception_pill.jpg)